Efficacy and safety of mesenchymal stem cell injections for knee osteoarthritis: A systematic review and meta-analysis
Xinguang Zhang,Cunbao Cui,Feng Lin
DOI: https://doi.org/10.4103/jrms.jrms_515_23
2024-10-01
Journal of Research in Medical Sciences
Abstract:A chronic joint illness called osteoarthritis (OA) is typified by secondary osteogenesis and articular cartilage degradation. Millions of individuals worldwide suffer from OA, a widespread joint condition that is more common in those over 60 years. [ 1 ] Although several treatment options are available for OA, including exercise, medication, and surgery, none of them can promote the regeneration of degenerated tissue. [ 2 ] Mesenchymal stem cells (MSCs) have emerged as a promising treatment option for OA due to their ability to differentiate into chondrocytes and modulate the immune system. [ 2 , 3 ] MSCs have become the most extensively explored new therapeutic agents for OA. [ 4 ] OA is a destructive joint disease, in which the synovial joints are involved, and the joint cartilage is gradually destroyed. [ 5 ] There is a change in the function of the whole joint, including the meniscus of the knee, the ligament around the joint, and the bone under the cartilage. [ 6 ] The risk factors that cause this complication include age, gender, [ 7 ] genetic, [ 8 ] obesity, [ 9 ] previous injury, [ 10 ] and sport. [ 11 ] OA disorder is common in the United States, it occurs in older, and in terms of gender, it is more common in women than men. Pain, joint swelling, and synovitis are clinical symptoms of the disease. [ 12 ] One of the main gold standards for its diagnosis is tissue biopsy, [ 13 ] but other techniques such as magnetic resonance imaging, [ 14 ] radiography are useful for diagnosis; radiographic findings include joint space reduction, osteophysis, subcartilage, sclerosis, and cyst formation. [ 15 ]
medicine, general & internal